Palvella Therapeutics PVLA
NASDAQ PVLA
$163.94 -4.77 (-2.83%)
At close: Nov 11, 2026 · 4:00 PM EST

Palvella Therapeutics (PVLA) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Palvella Therapeutics (PVLA) reported Return on Capital Employed [ROCE] of -23.41% for Q2 2026, up 16.23 percentage points from -39.64% a year earlier and up 6.48 percentage points from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Palvella Therapeutics posted Return on Capital Employed [ROCE] of -61.71%, down 22.40 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of -28.10 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -39.31% in FY2024 (-15.17 pp), -24.14% in FY2023 (+25.29 pp), -49.43% in FY2022 (+16.40 pp) and -65.84% in FY2021 (-32.22 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since Q3 2024.
  • Year over year, Return on Capital Employed [ROCE] gained in three of the last eight quarters, with an average year-over-year change of -7.77 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2024 (a gain of 129.15 percentage points); the low point was Q3 2025 (a drop of 72.48 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -29.88% (Q1 2026), -74.37% (Q4 2025) and -52.75% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Palvella Therapeutics 2.47 Bn 2.23 Bn - -30.36%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -30.36%
Jun 30, 2026 -23.41%
Mar 31, 2026 -29.88%
Dec 31, 2025 -74.37%
Sep 30, 2025 -52.75%
Jun 30, 2025 -39.64%
Mar 31, 2025 -27.00%
Dec 31, 2024 -33.29%
Sep 30, 2024 19.73%
Jun 30, 2024 -14.76%
Mar 31, 2024 17.13%
Dec 31, 2023 -38.16%
Sep 30, 2023 -82.46%
Jun 30, 2023 -73.49%
Mar 31, 2023 -112.02%
Dec 31, 2022 -71.57%
Sep 30, 2022 -58.67%
Jun 30, 2022 -55.23%
Mar 31, 2022 -51.23%
Dec 31, 2021 -47.85%
API Access

Palvella Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PVLA&period=max&api_key=YOUR_API_KEY